.Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J05A_DirectActingAntivirals.J05AF12_Clevudine.Clevudine

Information

name:Clevudine
ATC code:J05AF12
route:oral
n-compartments1

Clevudine is a nucleoside analog antiviral drug primarily developed for the treatment of chronic hepatitis B virus (HBV) infection. It inhibits DNA synthesis of HBV by acting as a reverse transcriptase inhibitor. Clevudine is not currently approved for use in the United States or many other major markets, but was approved and used in certain Asian countries.

Pharmacokinetics

Pharmacokinetic parameters reported for adult healthy volunteers and patients with chronic hepatitis B following oral administration.

References

    Revisions

    Generated at 2025-07-21T18:21:10Z by OpenModelicaOpenModelica 1.25.1 using GenerateDoc.mos